PML: underdiagnosed in MS patients on natalizumab. [electronic resource]
Producer: 20100607Description: 564; author reply 564-5 p. digitalISSN:- 1474-4465
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Disease Progression
- Early Diagnosis
- Europe -- epidemiology
- Humans
- Immunologic Factors -- therapeutic use
- Incidence
- Leukoencephalopathy, Progressive Multifocal -- diagnosis
- Multiple Sclerosis -- diagnosis
- Natalizumab
- Review Literature as Topic
- United States -- epidemiology
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.